The regulation of muscle mass by endogenous glucocorticoids
暂无分享,去创建一个
[1] J. Seckl,et al. 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. , 2013, Physiological reviews.
[2] J. Daly,et al. Glucocorticoid blockade does not abrogate tumor-induced cachexia. , 1999, Nutrition and cancer.
[3] D. Mann,et al. TNF-acts via p 38 MAPK to stimulate expression of the ubiquitin ligase atrogin 1 / MAFbx in skeletal muscle , 2005 .
[4] M. Exton. Infection-Induced Anorexia: Active Host Defence Strategy , 1997, Appetite.
[5] N. Offner,et al. The initiation factor eIF 3f is a major target for Atrogin 1 / MAFbx function in skeletal muscle atrophy , 2013 .
[6] D. Attaix,et al. Myostatin Gene Deletion Prevents Glucocorticoid- Induced Muscle Atrophy , 2022 .
[7] W. Mitch,et al. Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. , 1986, The Journal of clinical investigation.
[8] Charles Keller,et al. NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. , 2013, The Journal of clinical investigation.
[9] P. Felig,et al. Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. , 1973, The Journal of clinical investigation.
[10] J. Wang,et al. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. , 1996, The Journal of clinical investigation.
[11] H. Cushing. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932. , 1994, Obesity research.
[12] Yanjun Dong,et al. Myostatin Suppression of Akirin1 Mediates Glucocorticoid-Induced Satellite Cell Dysfunction , 2013, PloS one.
[13] W. Alkema,et al. Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor , 2010, BMC Genomics.
[14] D. Lacey,et al. Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival , 2010, Cell.
[15] T. Speed,et al. Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling , 2012, Proceedings of the National Academy of Sciences.
[16] D J Glass,et al. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.
[17] Se-Jin Lee,et al. Regulation of myostatin activity and muscle growth , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Goldberg,et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] N. Agell,et al. Muscle hypercatabolism during cancer cachexia is not reversed by the glucocorticoid receptor antagonist RU38486. , 1996, Cancer letters.
[20] D. Marks,et al. Pathophysiology and treatment of inflammatory anorexia in chronic disease , 2010, Journal of cachexia, sarcopenia and muscle.
[21] D. Marks,et al. Cancer‐ and endotoxin‐induced cachexia require intact glucocorticoid signaling in skeletal muscle , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] S. Anker,et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). , 2013, European heart journal.
[23] S. Bhatnagar,et al. The TWEAK–Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice , 2010, The Journal of cell biology.
[24] B. Langley,et al. Myostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression* , 2002, The Journal of Biological Chemistry.
[25] L. Ellisen,et al. Dexamethasone Represses Signaling through the Mammalian Target of Rapamycin in Muscle Cells by Enhancing Expression of REDD1* , 2006, Journal of Biological Chemistry.
[26] S. Bhasin,et al. Characterization of 5'-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. , 2001, American journal of physiology. Endocrinology and metabolism.
[27] J. Spranger,et al. Skeletal Muscle 11beta-HSD1 Controls Glucocorticoid-Induced Proteolysis and Expression of E3 Ubiquitin Ligases Atrogin-1 and MuRF-1 , 2011, PloS one.
[28] R. Huupponen,et al. Hepatic metabolism and distribution of mifepristone and its metabolites in rats. , 1994, Human reproduction.
[29] A. Csibi,et al. MAFbx/Atrogin-1 Controls the Activity of the Initiation Factor eIF3-f in Skeletal Muscle Atrophy by Targeting Multiple C-terminal Lysines* , 2009, Journal of Biological Chemistry.
[30] P. Sawchenko,et al. Cerebrovascular Cyclooxygenase-1 Expression, Regulation, and Role in Hypothalamic-Pituitary-Adrenal Axis Activation by Inflammatory Stimuli , 2009, The Journal of Neuroscience.
[31] L. Tessitore,et al. Pharmacological interference with tissue hypercatabolism in tumour-bearing rats. , 1994, The Biochemical journal.
[32] C. Y. Wang,et al. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. , 2000, Science.
[33] S. Bodine,et al. The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. , 2008, American journal of physiology. Endocrinology and metabolism.
[34] During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation , 2009, The Journal of cell biology.
[35] J. Mages,et al. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock , 2006, The Journal of experimental medicine.
[36] S. Bodine,et al. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids , 2011, The Journal of physiology.
[37] Takashi Ushida,et al. Translational Suppression of Atrophic Regulators by MicroRNA-23a Integrates Resistance to Skeletal Muscle Atrophy* , 2011, The Journal of Biological Chemistry.
[38] A. Goldberg,et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] M. Kluger. The evolution and adaptive value of fever. , 1978, American scientist.
[40] W. Mitch,et al. Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. , 2009, The Journal of clinical investigation.
[41] J. Cidlowski,et al. Glucocorticoid receptor signaling in health and disease. , 2013, Trends in pharmacological sciences.
[42] Nicholas Ling,et al. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF‐κB‐independent, FoxO1‐dependent mechanism , 2006 .
[43] V. Baracos,et al. Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic–pituitary–adrenal axis , 2011, The Journal of experimental medicine.
[44] Yi-Ping Li,et al. Curcumin prevents lipopolysaccharide‐induced atrogin‐1/MAFbx upregulation and muscle mass loss , 2007, Journal of cellular biochemistry.
[45] P. Sawchenko,et al. Type 1 interleukin‐1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL‐1–induced cellular activation , 1995, The Journal of comparative neurology.
[46] A. Goldberg,et al. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[47] K. Buller,et al. Circumventricular Organs: Gateways to the Brain Role Of Circumventricular Organs In Pro‐Inflammatory Cytokine‐Induced Activation Of The Hypothalamic– Pituitary–Adrenal Axis , 2001, Clinical and experimental pharmacology & physiology.
[48] D. Sabatini,et al. mTOR Signaling in Growth Control and Disease , 2012, Cell.
[49] W. V. Berghe,et al. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[50] P. Wei,et al. Transrepression of c-jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-jun promoter. , 1998, Molecular endocrinology.
[51] A. Goldberg,et al. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. , 1983, The New England journal of medicine.
[52] W. Mitch,et al. Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis. , 1987, The Journal of clinical investigation.
[53] N. Offner,et al. The initiation factor eIF3‐f is a major target for Atrogin1/MAFbx function in skeletal muscle atrophy , 2008, The EMBO journal.
[54] P. Sawchenko,et al. Evidence for an Intramedullary Prostaglandin-Dependent Mechanism in the Activation of Stress-Related Neuroendocrine Circuitry by Intravenous Interleukin-1 , 1997, The Journal of Neuroscience.
[55] Y. Itoyama,et al. NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. , 2007, The Journal of clinical investigation.
[56] S. Melmed,et al. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. , 1995, The Journal of clinical investigation.
[57] H. Zhang,et al. Endothelial-Specific Knockdown of Interleukin-1 (IL-1) Type 1 Receptor Differentially Alters CNS Responses to IL-1 Depending on Its Route of Administration , 2007, The Journal of Neuroscience.
[58] K. Seibert,et al. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[59] S. Powers,et al. p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting. , 2010, American journal of physiology. Cell physiology.
[60] W. Frontera,et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. , 2004, Cell.
[61] C. Lang,et al. Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle. , 2007, American journal of physiology. Endocrinology and metabolism.
[62] L. Muglia,et al. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[63] Lisa Martin,et al. Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer , 2009, Clinical Cancer Research.
[64] M. Almeida,et al. Glucocorticoids and Tumor Necrosis Factor α Increase Oxidative Stress and Suppress Wnt Protein Signaling in Osteoblasts* , 2011, The Journal of Biological Chemistry.
[65] Keiichi Fukuda,et al. Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. , 2011, Cell metabolism.
[66] S. W. Wendelaar Bonga,et al. The stress response in fish. , 1997, Physiological reviews.
[67] H. Besedovsky,et al. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. , 1987, Science.
[68] M. Sandri. Autophagy in health and disease. 3. Involvement of autophagy in muscle atrophy. , 2010, American journal of physiology. Cell physiology.
[69] R. Renkawitz,et al. The glucocorticoid receptor. , 1991, Biochimica et biophysica acta.
[70] Michael Karin,et al. p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling , 2009, Cell.
[71] C. Libert,et al. Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation. , 2012, The Journal of clinical investigation.
[72] A. Goldberg,et al. Patterns of gene expression in atrophying skeletal muscles: response to food deprivation , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[73] P. Herrlich,et al. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor , 2001, The EMBO journal.
[74] Sandhya Sriram,et al. Muscle-specific MicroRNA1 (miR1) Targets Heat Shock Protein 70 (HSP70) during Dexamethasone-mediated Atrophy* , 2013, The Journal of Biological Chemistry.
[75] ChulHun Kang,et al. Mechanism of glucocorticoid-induced oxidative stress in rat hippocampal slice cultures. , 2009, Canadian journal of physiology and pharmacology.
[76] P. Hasselgren,et al. PPARβ/δ Regulates Glucocorticoid- and Sepsis-Induced FOXO1 Activation and Muscle Wasting , 2013, PloS one.
[77] Marco Sandri,et al. Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.
[78] P. Gluckman,et al. The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli. , 2012, Cell metabolism.
[79] HORMONAL REGULATION , 1938, British medical journal.
[80] J. Wrana,et al. Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis , 2003, Molecular and Cellular Biology.
[81] N. Rosenthal,et al. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. , 2005, The Journal of clinical investigation.
[82] D. Allen,et al. Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. , 2011, American journal of physiology. Cell physiology.
[83] H. Cushing. The Basophil Adenomas of the Pituitary Body and Their Clinical Manifestations (Pituitary Basophilism) , 1964 .
[84] Shuhong Zhao,et al. Identification of microRNAs involved in dexamethasone-induced muscle atrophy , 2013, Molecular and Cellular Biochemistry.
[85] T. Claus,et al. Hormonal regulation of hepatic gluconeogenesis and glycolysis. , 1988, Annual review of biochemistry.
[86] A. Goldberg,et al. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. , 1993, The American journal of physiology.
[87] K. H. Richter,et al. The DNA Binding-Independent Function of the Glucocorticoid Receptor Mediates Repression of Ap-1–Dependent Genes in Skin , 1999, The Journal of cell biology.
[88] Qing Zhao,et al. TRAF6 Inhibition Rescues Dexamethasone-Induced Muscle Atrophy , 2014, International journal of molecular sciences.
[89] D. Laber,et al. 11 { beta }-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle , 2011 .
[90] R. Sapolsky,et al. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. , 1987, Science.
[91] K. Kalantar-Zadeh,et al. Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[92] S. Bodine,et al. Altered gene expression patterns in muscle ring finger 1 null mice during denervation- and dexamethasone-induced muscle atrophy. , 2013, Physiological genomics.
[93] S. Rakhilin,et al. The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. , 2007, Cell metabolism.
[94] Nicolas Lützner,et al. FOXO3 Is a Glucocorticoid Receptor Target and Regulates LKB1 and Its Own Expression Based on Cellular AMP Levels via a Positive Autoregulatory Loop , 2012, PloS one.
[95] B. Hart. Biological basis of the behavior of sick animals , 1988, Neuroscience & Biobehavioral Reviews.
[96] K. Kaestner,et al. DNA Binding of the Glucocorticoid Receptor Is Not Essential for Survival , 1998, Cell.
[97] P. Hasselgren,et al. Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. , 2003, The international journal of biochemistry & cell biology.
[98] Alexander Doyle,et al. Toll‐like receptor 4 mediates lipopolysaccharide‐induced muscle catabolism via coordinate activation of ubiquitin‐proteasome and autophagy‐lysosome pathways , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[99] Steven F. Maier,et al. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication , 1995, Neuroscience Letters.
[100] K. D. Zylan,et al. Article , 1996, Physiology & Behavior.
[101] C. Dinarello,et al. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. , 1986, Science.
[102] H. D. Hoberman. Endocrine Regulation of Amino Acid and Protein Metabolism during Fasting * , 1950, The Yale journal of biology and medicine.
[103] J. Fischer,et al. Tumour necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms , 1992, Mediators of inflammation.
[104] A. Goldberg,et al. FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.
[105] Jiandie D. Lin,et al. PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription , 2006, Proceedings of the National Academy of Sciences.